Description: This session will examine bias from a social science perspective. It will discuss the three types of systemic biases using the National Institute of Standards and Technology (NIST) model. The NIST model details the three types as historical bias, societal bias, and institutionalbias. The session will also provide several examples of each type to provide a framework for identifying the social structure of bias.

Description: "Hear AM Best rating analysts discuss the rating process and the best capital adequacy ratio (BCAR), a quantitative foundation for AM Best’s assessment of carriers’ financial strength. The benchmarking of BCAR scores for various company types (national MCOs, BCBS plans, smaller regional plans) will be discussed. Look at how changes in investment and underwriting environment impacted the results over the past several years. Further, AM Best’s view of the quality of capital and various factors impacting the overall assessment of the balance sheet strength will be discussed. By attending this session, you will: Gain an understanding of AM Best’s building block approach to ratings and how the BCAR results fit into the process. Learn the differences between RBC and BCAR models. Learn how various factors—e.g. liquidity, financial flexibility, financial leverage, the org structure—impact the final AM Best assessment of health companies' capital."

Description: Artificial intelligence is rapidly transforming the investment landscape. From natural language processing and large language models to physical AI applications like robotics, autonomous vehicles, and drones, the evolution of AI is reshaping both how we analyze data and where we find opportunity. We’ll begin by exploring the evolution of AI, which is already driving disruption across industries such as coding, customer service, and marketing. However, the future of AI is physical AI (drones, AVs, robotics). With valuations already stretched, and growing concerns about the “circular economy” and bubble risks, investors should focus on high-quality tech companies that generate free cash flow and deliver strong returns on invested capital. We'll explore examples of interesting companies across the globe: Meta, Alphabet, and Uber in the US; ASML in Europe; Tokyo Electron in Japan; TSMC in Taiwan; and BYD in China. The session will also examine how natural language processing and large language models are reshaping the way quantitative and fundamental managers extract insights from raw data. We’ll highlight how these tools are being deployed to enhance understanding of risk and return, and how they’re increasingly supporting collaboration between quant and fundamental teams.

Description: Explore key findings of an SOA-funded research paper on telehealth that will be published in 2023. The COVID-19 pandemic initially caused some health care delivery to shift away from in-person transactions to a more digital form of transactions, including telehealth, e-mails, remote patient monitoring and other forms of communication.

Description: "This session will provide a comprehensive overview of key aspects related to the GAAP/VM-21 valuation for RILA. We will discuss how VM-21 can reward companies for making conservative decisions and examine the key factors that drive different levels of VM-21 reserves and capital. We will also cover how ALM management for RILA differs from other annuities. Attendees will gain insights into practical considerations, challenges, and solutions in implementing RILA valuation."

Description: Focus on how innovative health care organizations develop their value proposition for their intended buyers. Presenters will share information about their specific solution and the methods used to derive credible savings estimates, ROI, and performance guarantees. Learn about data utilized, the methods deployed, advantages, disadvantages, and buyers' reaction. This session is expected to be technical, highly informative, and interactive with audience members.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: In this talk, we look at two behavioral aspects: from end customers perspective and through the lens of underwriters. We will examine simple rules to improve the insurance underwriting decision to judge whether a risk is insurable and whether they have impact on increasing underwriting decision quality.

Description: Are you ready to supercharge your career? Join us for an exciting webcast where industry experts will share how to leverage mentoring and networking for career success. Discover how these powerful tools can transform your professional journey, provide invaluable insights, and open doors to new opportunities. In this dynamic session, our speakers will share their personal stories and practical tips on building meaningful mentoring relationships. You’ll learn proven networking strategies to connect with influential professionals and accelerate your career growth. Don’t miss this chance to gain insider knowledge from industry leaders and receive actionable advice. Whether you’re just starting out or aiming to advance your career, this webcast will equip you with the tools and inspiration you need to succeed.

Description: In this webcast, we will speak with actuarial leaders who developed their personal brand over several years to better understand just how powerful having a personal brand can be in actuarial work.